Text & Content Analysis
This page analyzes how a selected category, entity, or narrative frame appears in recent news coverage within the specified time window. Metrics and breakdowns are derived from the active article corpus.
Explore by Category
Corpus KPIs
Entity
food and drug administration
Articles
3
From
2026-03-11 10:50:00+00
To
2026-04-08 20:01:35+00
Range
2026-03-10 19:44:43.087866+00 →
2026-04-09 19:44:43.087866+00
Who’s being talked about
Top Entities
| Entity | Label | Mentions | Actions |
|---|---|---|---|
| food and drug administration | ORG | 3 | 📊 🔍 🧲 |
| american | NORP | 2 | 📊 🔍 🧲 |
| about two | CARDINAL | 1 | 📊 🔍 🧲 |
| alaly | PERSON | 1 | 📊 🔍 🧲 |
| americans | NORP | 1 | 📊 🔍 🧲 |
| andrew nixon | PERSON | 1 | 📊 🔍 🧲 |
| announce fiscal year 2025 | ORG | 1 | 📊 🔍 🧲 |
| ap | ORG | 1 | 📊 🔍 🧲 |
| bmj medicine | ORG | 1 | 📊 🔍 🧲 |
| brazil | GPE | 1 | 📊 🔍 🧲 |
| burger | ORG | 1 | 📊 🔍 🧲 |
| center for social media and politics | ORG | 1 | 📊 🔍 🧲 |
| chiesi farmaceutici spa | ORG | 1 | 📊 🔍 🧲 |
| company | ORG | 1 | 📊 🔍 🧲 |
| congress | ORG | 1 | 📊 🔍 🧲 |
| donald trump | PERSON | 1 | 📊 🔍 🧲 |
| elfabrio | PERSON | 1 | 📊 🔍 🧲 |
| eli lillys | ORG | 1 | 📊 🔍 🧲 |
| facebook tweet email link threads link copied | WORK_OF_ART | 1 | 📊 🔍 🧲 |
| fda | ORG | 1 | 📊 🔍 🧲 |
| featured weekly ad | WORK_OF_ART | 1 | 📊 🔍 🧲 |
| gaucher | PERSON | 1 | 📊 🔍 🧲 |
| glp1 | PRODUCT | 1 | 📊 🔍 🧲 |
| glp1s | PERSON | 1 | 📊 🔍 🧲 |
| grace silva | PERSON | 1 | 📊 🔍 🧲 |
Articles included
Top entities
Top sources
Top narrative frames
| Pub Date | Category | Domain | Title | Analyze | Author | Sent | Score |
|---|---|---|---|---|---|---|---|
| 2026-04-08 20:01:35+00 | Health |
|
RFK Jr. is launching a podcast to expose ‘lies’ that have made Americans sick | Analyze | CNN | 😐 neutral | 0.0852 |
| 2026-03-18 16:01:26+00 | Health |
|
Why quitting Ozempic and GLP-1s can be bad for your heart health | Analyze | Ken Alltucker | 😐 neutral | 0.0696 |
| 2026-03-11 10:50:00+00 | Business |
|
Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business Update on March 18, 2026 | Analyze | Protalix BioTherapeutics, Inc. | 😐 neutral | 0.1358 |